To compare their cytotoxic potential, CD19‐293 and CD19‐CAR‐T cells were co‐cultured with B‐ALL cells to evaluate their killing efficiency (Figure S5, Supporting Information). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.